Authors

Dr. Thompson is associate director, Pediatric Residency Program, Children’s Hospital Los Angeles.

Crystal Phend<BR>Reviewed by Robert Jasmer, MD; Assistant Professor of Medicine, University of California, San Francisco

D. Brady Pregerson, MD

Charles J. Lockwood, MD, MHCM

Dr. Lockwood, Editor-in-Chief, is Dean of the Morsani College of Medicine and Senior Vice President of USF Health, University of South Florida, Tampa. He can be reached at [email protected].

STEVEN A. KING, MD, MS

GREGORY RUTECKI, MD

Anna D. Garrett, PharmD, BCPS

Anna D. Garrett is a clinical pharmacist and president of Dr. Anna Garrett (www.drannagarrett.com). Her mission is to help women in midlife maximize their mojo! Contact her at [email protected].

Christine Blank

Contributing Editor Christine Blank is a freelance writer based in Florida.

Lisette Hilton

Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness for 25 years. Visit www.WordsComeAlive.com.

Salynn Boyles

Renee Dowling

Evan Brittain, MD, MSc

Patient Care Editorial Staff

Practical Cardiology Editorial Staff

Screening for Cardiovascular Disease

5 years ago

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

Endocrinology Network Editorial Staff

A. Shane Anderson, MD

Aaron Pumerantz, DO

Aaron Taylor Lee

Aisha T. Langford, PhD, MPH

Baricitinib vs. Placebo or Adalimumab for Rheumatoid Arthritis

10 years ago

Compared to placebo and adalimumab, the addition of once-daily oral baricitinib produced significant clinical improvements in RA patients, research shows.

Alyce Oliver, PhD, MD